Search Results for "Bayer Non Pharmac"
Matching Channels
Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...
Xofigo (radium-223 dichloride)
New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...
Lemtrada (alemtuzumab) is being developed by Sanofi in collaboration with Bayer Healthcare for the treatment of relapsing multiple sclerosis.
In addition to the Silicon Valley, California on the west coast of the USA is home to a biotechnology hub. 26% of all American biotechnology firms are located in this state, but they count for over...
Matching News
NZ's PHARMAC consults on funding for Iressa and Tarceva
The Pharmaceutical Management Agency of New Zealand, PHARMAC, is seeking feedback on a proposal to:
BIO Says New Zealand's Pharmac Hinders Development
The Biotechnology Industry Organization accused New Zealand's Pharmac of inhibiting pharmaceutical development in the country.
Pharmac Says 10% Of New Zealanders Prescribed Antidepressants
New Zealand's government drug purchaser, Pharmac, says 10% of the nation's population is taking prescribed antidepressants, an amount one academic psychiatrist said is excessive.
Sole-supplier contracts continue to cause controversy in New Zealand, even as PHARMAC defends the practice.
New Zealand's Pharmac Willing To Talk Price For Orphan-Hemophilia Drug
New Zealand's Pharmac said the drug-coverage agency is weighing the $421,000-a-year cost against the benefits of subsidizing Alexion's Soliris (eculizumab) in treating to a rare type of hemophilia.
New Zealand's PHARMAC to fund alternative treatments for asthma, scabies from Merck
New Zealand's Pharmaceutical Management Agency PHARMAC is to fund a treatment for pre-schoolers with recurrent wheezing despite using other therapies, and for people with exercise-induced asthma.
New Zealand’s Pharmac Drug-Buying Agency Sets Two-Tiered Funding
New Zealand’s drug-funding agency, Pharmac, has established a procedure for district health-board hospitals to standardize pharmaceutical treatments throughout the country.
New Zealand's PHARMAC agrees pricing deal with Sanofi for Arava
New Zealand's national pharmaceuticals funding agency, PHARMAC, has announced changes to the listings for leflunomide, French drug major Sanofi's (Euronext: SAN) arthritis drug Arava.
Matching PubMed Articles
A review of the determination of organic compounds in Bayer process liquors.
Bayer process liquors present a difficult and complex matrix to the analytical chemist, and the history of the application of modern analytical techniques to this problem is a case study in innovation...
Editorial: the importance of chemistry for the future of the pharma industry.
"Collaborative innovation"-regaining the edge in drug discovery.
